GO TO CMA Home
GO TO Inside CMA
GO TO Advocacy and Communications
GO TO Member Services
GO TO Publications
GO TO Professional Development
GO TO Clinical Resources

GO TO What's New
GO TO Contact CMA
GO TO Web Site Search
GO TO Web Site Map


CMAJ
CMAJ - January 12, 1999JAMC - le 12 janvier 1999

Prostate cancer: 8. Urinary incontinence and erectile dysfunction

Table 1: Options for treating erectile dysfunction after radical prostatectomy
Option Benefit Problems
Do nothing Little "fuss" May go against patient’s, partner’s and society’s expectations
Intracavernous injection of prostaglandin Prompt, reliable erection
Probably most effective
Intrusive
Transurethral suppository (prostaglandin) Prompt and safe
40% efficacy
Mildly intrusive
Older oral agents Non-intrusive Seldom effective
New oral agent (sildenafil) Non-intrusive
Efficacy probably similar to injection
Contraindicated if patient is receiving nitrates*
1-h onset time
Other new agents (e.g., phentolamine or apomorphine) Non-intrusive
Variable efficacy
Depends on drug class
Vacuum erection device Effective Intrusive, results in cold penis
Penile prosthesis Effective Invasive, irreversible
*It is unusual for patients who have undergone prostatectomy to use nitrates.

[Return to text]